Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study.
<h4>Background</h4>Our knowledge of how to better manage elevated blood pressure (BP) in the presence of comorbidities is limited, in part due to exclusion or underrepresentation of patients with multiple chronic conditions from major clinical trials. We aimed to investigate the burden a...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-06-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003674&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849331710745903104 |
|---|---|
| author | Jenny Tran Robyn Norton Dexter Canoy Jose Roberto Ayala Solares Nathalie Conrad Milad Nazarzadeh Francesca Raimondi Gholamreza Salimi-Khorshidi Anthony Rodgers Kazem Rahimi |
| author_facet | Jenny Tran Robyn Norton Dexter Canoy Jose Roberto Ayala Solares Nathalie Conrad Milad Nazarzadeh Francesca Raimondi Gholamreza Salimi-Khorshidi Anthony Rodgers Kazem Rahimi |
| author_sort | Jenny Tran |
| collection | DOAJ |
| description | <h4>Background</h4>Our knowledge of how to better manage elevated blood pressure (BP) in the presence of comorbidities is limited, in part due to exclusion or underrepresentation of patients with multiple chronic conditions from major clinical trials. We aimed to investigate the burden and types of comorbidities in patients with hypertension and to assess how such comorbidities and other variables affect BP levels over time.<h4>Methods and findings</h4>In this multiple landmark cohort study, we used linked electronic health records from the United Kingdom Clinical Practice Research Datalink (CPRD) to compare systolic blood pressure (SBP) levels in 295,487 patients (51% women) aged 61.5 (SD = 13.1) years with first recorded diagnosis of hypertension between 2000 and 2014, by type and numbers of major comorbidities, from at least 5 years before and up to 10 years after hypertension diagnosis. Time-updated multivariable linear regression analyses showed that the presence of more comorbidities was associated with lower SBP during follow-up. In hypertensive patients without comorbidities, mean SBP at diagnosis and at 10 years were 162.3 mm Hg (95% confidence interval [CI] 162.0 to 162.6) and 140.5 mm Hg (95% CI 140.4 to 140.6), respectively; in hypertensive patients with ≥5 comorbidities, these were 157.3 mm Hg (95% CI 156.9 to 157.6) and 136.8 mm Hg (95% 136.4 to 137.3), respectively. This inverse association between numbers of comorbidities and SBP was not specific to particular types of comorbidities, although associations were stronger in those with preexisting cardiovascular disease. Retrospective analysis of recorded SBP showed that the difference in mean SBP 5 years before diagnosis between those without and with ≥5 comorbidities was -9 mm Hg (95% CI -9.7 to -8.3), suggesting that mean recorded SBP already differed according to the presence of comorbidity before baseline. Within 1 year after the diagnosis, SBP substantially declined, but subsequent SBP changes across comorbidity status were modest, with no evidence of a more rapid decline in those with more or specific types of comorbidities. We identified factors, such as prescriptions of antihypertensive drugs and frequency of healthcare visits, that can explain SBP differences according to numbers or types of comorbidities, but these factors only partly explained the recorded SBP differences. Nevertheless, some limitations have to be considered including the possibility that diagnosis of some conditions may not have been recorded, varying degrees of missing data inherent in analytical datasets extracted from routine health records, and greater measurement errors in clinical measurements taken in routine practices than those taken in well-controlled clinical study settings.<h4>Conclusions</h4>BP levels at which patients were diagnosed with hypertension varied substantially according to the presence of comorbidities and were lowest in patients with multi-morbidity. Our findings suggest that this early selection bias of hypertension diagnosis at different BP levels was a key determinant of long-term differences in BP by comorbidity status. The lack of a more rapid decline in SBP in those with multi-morbidity provides some reassurance for BP treatment in these high-risk individuals. |
| format | Article |
| id | doaj-art-e7dc6015bd30492793586b6137b47c3b |
| institution | Kabale University |
| issn | 1549-1277 1549-1676 |
| language | English |
| publishDate | 2021-06-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj-art-e7dc6015bd30492793586b6137b47c3b2025-08-20T03:46:25ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762021-06-01186e100367410.1371/journal.pmed.1003674Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study.Jenny TranRobyn NortonDexter CanoyJose Roberto Ayala SolaresNathalie ConradMilad NazarzadehFrancesca RaimondiGholamreza Salimi-KhorshidiAnthony RodgersKazem Rahimi<h4>Background</h4>Our knowledge of how to better manage elevated blood pressure (BP) in the presence of comorbidities is limited, in part due to exclusion or underrepresentation of patients with multiple chronic conditions from major clinical trials. We aimed to investigate the burden and types of comorbidities in patients with hypertension and to assess how such comorbidities and other variables affect BP levels over time.<h4>Methods and findings</h4>In this multiple landmark cohort study, we used linked electronic health records from the United Kingdom Clinical Practice Research Datalink (CPRD) to compare systolic blood pressure (SBP) levels in 295,487 patients (51% women) aged 61.5 (SD = 13.1) years with first recorded diagnosis of hypertension between 2000 and 2014, by type and numbers of major comorbidities, from at least 5 years before and up to 10 years after hypertension diagnosis. Time-updated multivariable linear regression analyses showed that the presence of more comorbidities was associated with lower SBP during follow-up. In hypertensive patients without comorbidities, mean SBP at diagnosis and at 10 years were 162.3 mm Hg (95% confidence interval [CI] 162.0 to 162.6) and 140.5 mm Hg (95% CI 140.4 to 140.6), respectively; in hypertensive patients with ≥5 comorbidities, these were 157.3 mm Hg (95% CI 156.9 to 157.6) and 136.8 mm Hg (95% 136.4 to 137.3), respectively. This inverse association between numbers of comorbidities and SBP was not specific to particular types of comorbidities, although associations were stronger in those with preexisting cardiovascular disease. Retrospective analysis of recorded SBP showed that the difference in mean SBP 5 years before diagnosis between those without and with ≥5 comorbidities was -9 mm Hg (95% CI -9.7 to -8.3), suggesting that mean recorded SBP already differed according to the presence of comorbidity before baseline. Within 1 year after the diagnosis, SBP substantially declined, but subsequent SBP changes across comorbidity status were modest, with no evidence of a more rapid decline in those with more or specific types of comorbidities. We identified factors, such as prescriptions of antihypertensive drugs and frequency of healthcare visits, that can explain SBP differences according to numbers or types of comorbidities, but these factors only partly explained the recorded SBP differences. Nevertheless, some limitations have to be considered including the possibility that diagnosis of some conditions may not have been recorded, varying degrees of missing data inherent in analytical datasets extracted from routine health records, and greater measurement errors in clinical measurements taken in routine practices than those taken in well-controlled clinical study settings.<h4>Conclusions</h4>BP levels at which patients were diagnosed with hypertension varied substantially according to the presence of comorbidities and were lowest in patients with multi-morbidity. Our findings suggest that this early selection bias of hypertension diagnosis at different BP levels was a key determinant of long-term differences in BP by comorbidity status. The lack of a more rapid decline in SBP in those with multi-morbidity provides some reassurance for BP treatment in these high-risk individuals.https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003674&type=printable |
| spellingShingle | Jenny Tran Robyn Norton Dexter Canoy Jose Roberto Ayala Solares Nathalie Conrad Milad Nazarzadeh Francesca Raimondi Gholamreza Salimi-Khorshidi Anthony Rodgers Kazem Rahimi Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. PLoS Medicine |
| title | Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. |
| title_full | Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. |
| title_fullStr | Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. |
| title_full_unstemmed | Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. |
| title_short | Multi-morbidity and blood pressure trajectories in hypertensive patients: A multiple landmark cohort study. |
| title_sort | multi morbidity and blood pressure trajectories in hypertensive patients a multiple landmark cohort study |
| url | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003674&type=printable |
| work_keys_str_mv | AT jennytran multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT robynnorton multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT dextercanoy multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT joserobertoayalasolares multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT nathalieconrad multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT miladnazarzadeh multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT francescaraimondi multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT gholamrezasalimikhorshidi multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT anthonyrodgers multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy AT kazemrahimi multimorbidityandbloodpressuretrajectoriesinhypertensivepatientsamultiplelandmarkcohortstudy |